A single induction agent
may cause haemodynamic changes.
The induction phase is the most stressful moment of general anaesthesia (3), and the haemodynamic response is explicitly evoked in rapid-sequence induction (RSI) (4), a process whereby pharmacologic agents, specifically an induction agent
and a neuromuscular blocking agent are administered in a rapid succession to facilitate endotracheal intubation (5).
Specialty-specific differences emerged for choice of induction agent
At times, the induction agent
alone is necessary to sustain labour and effect delivery, but at times, oxytocin, after an appropriate interval, is required.
Jurox's and technical force is focused on introducing its flagship anesthesia induction agent
, Alfaxan, added its COO and U.S business leader, Jim Van Proosdy.
The history of propofol from its introduction as a sedativehypnotic, intravenous anesthesia induction agent
in Europe in 1977 to its worldwide predominance as an intravenous anesthesia induction agent
today has been wrought with controversy, especially its use as a lethal intravenous injection agent in death-penalty-directed executions in the U.S.
Although steroids use in maintenance immunosuppression was associated with lower risks for acute rejection and death-censored graft loss in the main Cox models (Figure 2), the Cox model with interaction in Figure 6 did not show significant associations between death-censored graft loss and the variable termed: induction agent
(ATG and alemtuzumab) x steroid use.
In the present study, ketamine was included as part of a balanced anesthetic technique and not as the anesthetic induction agent
. The ketamine dose of 3mg [kg.sup.-1] was chosen with the aim of producing analgesia and not anesthesia.
Etomidate is a preferred induction agent
because of its substantially increased lipid solubility for critically ill patients whose blood pressure should be maintained at a stable level.
Should Ketamine be used as an induction agent
in traumatic brain injury?
The results are consistent with the most recent Cochrane meta-analysis, which called for further research comparing letrozole with clomiphene as a primary ovulation induction agent
in polycystic ovary syndrome (PCOS) because of low-quality evidence (Cochrane Database Syst.